By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: ATI Advisory Launches Public Dashboard on C-SNPs and Eligible Populations
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > Health > ATI Advisory Launches Public Dashboard on C-SNPs and Eligible Populations
ATI Advisory Launches Public Dashboard on C-SNPs and Eligible Populations
Health

ATI Advisory Launches Public Dashboard on C-SNPs and Eligible Populations

GlobeNews Wire
Last updated: 19/05/2026 3:37 AM
GlobeNews Wire
Published: 19/05/2026
Share
SHARE

New resource offers insight into the characteristics of Medicare beneficiaries enrolling in C-SNP and eligible enrollees in other plan types, including dual eligibles and beneficiaries with frailty, as MA plans face increasing care need complexity

May 18, 2026 17:08 ET  | Source: ATI Advisory

Washington, DC, May 18, 2026 (GLOBE NEWSWIRE) — High-performing Chronic Condition Special Needs Plans (C-SNPs) require precise population targeting, provider alignment, and operational readiness. To support industry decision-making, ATI Advisory announced the launch of a publicly available dashboard, “C-SNPs and Their Enrolled Populations: Composition, Risk, and Outcomes.” Based on analysis of 100% Medicare Advantage (MA) encounter data, this dashboard provides data-driven insights on C-SNP enrollees and eligible enrollees in other plan types in 2023.

The launch of this dashboard comes as MA plans face sustained utilization pressure and increasing care need complexity across the market. Many beneficiaries enrolled in MA today are older and more clinically complex, with multiple chronic conditions, functional limitations, or significant social needs that require more coordinated and sustained support. In this environment, plans are increasingly evaluating population-specific strategies and specialized care delivery models, including C-SNPs.

ATI’s dashboard provides a starting point for understanding the current C-SNP enrollee population, as well as the C-SNP-eligible population enrolled in other plan types. As enrollment in C-SNPs grows, stakeholders need a clearer understanding of how these plans fit within the broader MA landscape. Users can explore reports on population composition, risk, and medical and long-term care experience by state and plan type in 2023.

ATI Chief Growth and Innovation Officer Allison Rizer explained the timeliness of this tool: “Medicare Advantage plans are increasingly serving individuals with overlapping clinical, functional, and social needs, driving the growth of more tailored, specialized products. We’re excited to launch this resource to help the market better understand who is enrolling in options like C-SNPs, and how those populations compare across plan types, so plans and policymakers can design more effective, targeted approaches.”

By making these analyses publicly available, ATI aims to support more informed decision-making among plans, policymakers, providers, and other stakeholders evaluating how specialized models fit within a changing MA market.

About ATI Advisory

ATI Advisory is a healthcare research and advisory services firm dedicated to system reform that improves health outcomes and makes care better for everyone. ATI guides public and private leaders in solving the most complex problems in healthcare through objective research, deep expertise, and bringing ideas to action.

Press Inquiries

Olivia Blumenshine
olivia [at] atiadvisory.com
https://atiadvisory.com/

Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma
Teqball Added to the 2026 Asian Games Sports Programme
NYSE Content Advisory: Pre-market update + U.S. & EU reach trade deal
Cellebrite Announces 20 JUSTYS Award Winners at C2C User Summit 2026
Phemex Introduces 24/7 TradFi Futures Trading with 0-Fee Carnival, Creating an All-in-One Trading Hub
TAGGED:advisoryandatic-snpsdashboardeligiblelaunchesnewspopulationspublic
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
TOMI Environmental Solutions, Inc. Reports Q3 2025 Financial Results and Outlines Growth Initiatives
Health

TOMI Environmental Solutions, Inc. Reports Q3 2025 Financial Results and Outlines Growth Initiatives

GlobeNews Wire
GlobeNews Wire
15/11/2025
IEEE Future Networks World Forum 2025: India is ready to become a self-reliant, future-ready, and globally influential nation by 2047
5G-A Users Reach 10 Million in China: Huawei Showcases 5G-A Development and Value of Scenario-based AI
Bybit Detects and Blocks Coordinated Fake Deposit Attacks, Preventing Over $1 Billion DOT in Potential Losses
FAIR PLAY MENARINI INTERNATIONAL AWARD, LUIS FIGO JOINS THE GREAT SPORTS STARS ACKNOWLEDGED IN 2025
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?